Resistance to Pembrolizumab and Axitinib in Renal Cell Carcinoma: Clinical and Genomic Evaluation. Journal of Kidney Cancer, [S. l.], v. 7, n. 1, p. 7–11, 2020. DOI: 10.15586/jkcvhl.2020.135. Disponível em: https://jkcvhl.com/~jkcvhlco/index.php/jkcvhl/article/view/135. Acesso em: 21 apr. 2026.